Literature DB >> 3714804

Large theophylline requirements due to high theophylline clearance: verification by the antipyrine test.

G T Blyden, B W LeDuc, D J Greenblatt.   

Abstract

An asthmatic patient required very high doses of theophylline (2.88 g/day by intravenous infusion) to maintain an adequate serum theophylline concentration (12 micrograms/ml). His cigarette smoking and concurrent treatment with phenytoin were suspected to have produced hepatic microsomal enzyme induction, causing unusually high theophylline clearance. The intravenous antipyrine test demonstrated an unusually short half-life (5.5 h) and high clearance (95 ml/min) of antipyrine, consistent with induced clearance of antipyrine. Formation of the 4-hydroxy metabolite of antipyrine was disproportionately induced. Thus the antipyrine test can be of clinical value for documenting hepatic microsomal enzyme induction in patients with low steady-state theophylline concentrations despite high maintenance doses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3714804     DOI: 10.1159/000138173

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

1.  Effect of antipyrine coadministration on the kinetics of acetaminophen and lidocaine.

Authors:  G T Blyden; D J Greenblatt; B W LeDuc; J M Scavone
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  Influence of subject age on the inhibition of oxidative metabolism by ciprofloxacin.

Authors:  N M Waite; M J Rybak; D J Krakovsky; J D Steinberg; L H Warbasse; D J Edwards
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Lack of effect of influenza vaccine on the pharmacokinetics of antipyrine, alprazolam, paracetamol (acetaminophen) and lorazepam.

Authors:  J M Scavone; G T Blyden; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1989-03       Impact factor: 6.447

4.  Two- and four-day rifampin chemoprophylaxis regimens induce oxidative metabolism.

Authors:  S M Borcherding; T L Bastian; T H Self; N Abou-Shala; B W LeDuc; R L Lalonde
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.